Association between targeted inflammatory proteomics and insulin sensitivity as well as beta-cell function in subjects with normal glucose tolerance
Journal of Molecular Cell Biology · 2025
DOI: 10.1093/jmcb/mjaf035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2025. Verfasst von Anran Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai…. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Insulin Resistance, Proteomics, Inflammation. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Shanghai Municipal Key Clinical Specialty, Shanghai Research Center for Endocrine and Metabolic Diseases, National Natural Science Foundation of China.
Abstract (Originalsprache)
Obese individuals even with normal glucose tolerance (NGT) are at higher risk for developing type 2 diabetes (T2D), and obesity is associated with inflammation. However, mechanisms linking inflammation to beta-cell function and insulin sensitivity in NGT individuals are not fully understood. We aimed to investigate the relationships between inflammation-related proteins (IRPs) and insulin dynamics in NGT subjects. The explorations were conducted using data from 1109 non-diabetes subjects aged 40–44 with normal or excess body weight and 21 Chinese NGT subjects aged 22–32 with accurate metabolic assessment. IRPs were detected with Olink technology. Insulin sensitivity and beta-cell function were evaluated with hyperinsulinemic–euglycemic clamp and hyperglycemic clamp. Eight associators were identified with obesity in NGT subjects, among which MCP-3, IL-6, TWEAK, HGF, and CST5 also showed associations in non-diabetes people. Four IRPs were linked to insulin sensitivity, with IL-24 being a novel finding. Seven IRPs were related to beta-cell function, including novel associators CD244, CD40, and IL-15RA. Moreover, most IRPs were interconnected, with IL-6 as the hub. In conclusion, insulin sensitivity and beta-cell function are related to IRPs involved in chemotaxis, activation of immune cells, and cell proliferation, which might provide valuable information for the understanding of the mechanisms associated with T2D pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai K…
- Department of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Förderung
- National Key Research and Development Program of China
- Shanghai Municipal Key Clinical Specialty, Shanghai Research Center for Endocrine and Metabolic Diseases
- National Natural Science Foundation of China
Zitieren
APA
Chen, A., Li, Q., Mao, H., Lu, Y., Liu, D., Zhang, L., Fang, Q., Wang, C., Li, H., & Jia, W. (2025). Association between targeted inflammatory proteomics and insulin sensitivity as well as beta-cell function in subjects with normal glucose tolerance. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjaf035
Vancouver
Chen A, Li Q, Mao H, Lu Y, Liu D, Zhang L, et al. Association between targeted inflammatory proteomics and insulin sensitivity as well as beta-cell function in subjects with normal glucose tolerance. Journal of Molecular Cell Biology. 2025. doi:10.1093/jmcb/mjaf035
BibTeX
@article{Chen2025,
author = {Chen, Anran and Li, Qian and Mao, Hongfeng and Lu, Yuwei and Liu, Dan and Zhang, Lei and Fang, Qichen and Wang, Chen and Li, Huating and Jia, Weiping},
title = {Association between targeted inflammatory proteomics and insulin sensitivity as well as beta-cell function in subjects with normal glucose tolerance},
journal = {Journal of Molecular Cell Biology},
year = {2025},
doi = {10.1093/jmcb/mjaf035}
}
EUVIMED